89 related articles for article (PubMed ID: 19680267)
21. Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis.
Fulda S; Meyer E; Friesen C; Susin SA; Kroemer G; Debatin KM
Oncogene; 2001 Mar; 20(9):1063-75. PubMed ID: 11314043
[TBL] [Abstract][Full Text] [Related]
22. Regulating Vav1 phosphorylation by the SHP-1 tyrosine phosphatase is a fine-tuning mechanism for the negative regulation of DISC formation and Fas-mediated cell death signaling.
Koncz G; Kerekes K; Chakrabandhu K; Hueber AO
Cell Death Differ; 2008 Mar; 15(3):494-503. PubMed ID: 18064043
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of CD95 apoptotic signaling by interferon-gamma in human osteoarthritic chondrocytes is associated with increased expression of FLICE inhibitory protein.
Grassi F; Piacentini A; Cristino S; Toneguzzi S; Facchini A; Lisignoli G
Arthritis Rheum; 2004 Feb; 50(2):498-506. PubMed ID: 14872492
[TBL] [Abstract][Full Text] [Related]
24. Lipid rafts and Fas/CD95 signaling in cancer chemotherapy.
Gajate C; Mollinedo F
Recent Pat Anticancer Drug Discov; 2011 Sep; 6(3):274-83. PubMed ID: 21762074
[TBL] [Abstract][Full Text] [Related]
25. Localization of Fas/CD95 into the lipid rafts on down-modulation of the phosphatidylinositol 3-kinase signaling pathway.
Bénéteau M; Pizon M; Chaigne-Delalande B; Daburon S; Moreau P; De Giorgi F; Ichas F; Rebillard A; Dimanche-Boitrel MT; Taupin JL; Moreau JF; Legembre P
Mol Cancer Res; 2008 Apr; 6(4):604-13. PubMed ID: 18403639
[TBL] [Abstract][Full Text] [Related]
26. The CD95/CD95 ligand system is not the major effector in anticancer drug-mediated apoptosis.
Tolomeo M; Dusonchet L; Meli M; Grimaudo S; D'Alessandro N; Papoff G; Ruberti G; Rausa L
Cell Death Differ; 1998 Sep; 5(9):735-42. PubMed ID: 10200532
[TBL] [Abstract][Full Text] [Related]
27. Calmodulin binding to the Fas-mediated death-inducing signaling complex in cholangiocarcinoma cells.
Chen Y; Pawar P; Pan G; Ma L; Liu H; McDonald JM
J Cell Biochem; 2008 Feb; 103(3):788-99. PubMed ID: 17654480
[TBL] [Abstract][Full Text] [Related]
28. The CD95(APO-1/Fas) DISC and beyond.
Peter ME; Krammer PH
Cell Death Differ; 2003 Jan; 10(1):26-35. PubMed ID: 12655293
[TBL] [Abstract][Full Text] [Related]
29. Actinomycin D-mediated sensitization of AIDS-Kaposi's sarcoma cells to Fas-mediated apoptosis: involvement of the mitochondrion-dependent pathway.
Mori S; Murakami-Mori K; Nakamura S; Bonavida B
Int J Oncol; 2002 Apr; 20(4):819-26. PubMed ID: 11894131
[TBL] [Abstract][Full Text] [Related]
30. Fas is expressed early in human thymocyte development but does not transmit an apoptotic signal.
Jenkins M; Keir M; McCune JM
J Immunol; 1999 Aug; 163(3):1195-204. PubMed ID: 10415014
[TBL] [Abstract][Full Text] [Related]
31. CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8.
Barnhart BC; Pietras EM; Algeciras-Schimnich A; Salmena L; Sayama K; Hakem R; Peter ME
Cell Death Differ; 2005 Jan; 12(1):25-37. PubMed ID: 15499374
[TBL] [Abstract][Full Text] [Related]
32. Characterisation of FAP-1 expression and CD95 mediated apoptosis in the A818-6 pancreatic adenocarcinoma differentiation system.
Winterhoff BJ; Arlt A; Duttmann A; Ungefroren H; Schäfer H; Kalthoff H; Kruse ML
Differentiation; 2012 Mar; 83(3):148-57. PubMed ID: 22364882
[TBL] [Abstract][Full Text] [Related]
33. Principles and mechanisms of CD95 activation.
Wajant H
Biol Chem; 2014 Dec; 395(12):1401-16. PubMed ID: 25153377
[TBL] [Abstract][Full Text] [Related]
34. CD95 ligation and intracellular membrane flow.
Reinehr R; Häussinger D
Biochem J; 2008 Aug; 413(3):e11-2. PubMed ID: 18613813
[TBL] [Abstract][Full Text] [Related]
35. The role of CD95 and CD95 ligand in cancer.
Peter ME; Hadji A; Murmann AE; Brockway S; Putzbach W; Pattanayak A; Ceppi P
Cell Death Differ; 2015 Apr; 22(4):549-59. PubMed ID: 25656654
[TBL] [Abstract][Full Text] [Related]
36. CD95 signaling in colorectal cancer.
Hoogwater FJ; Steller EJ; Westendorp BF; Borel Rinkes IH; Kranenburg O
Biochim Biophys Acta; 2012 Aug; 1826(1):189-98. PubMed ID: 22498253
[TBL] [Abstract][Full Text] [Related]
37. The multilevel regulation of CD95 signaling outcome.
Yurchenko M; Shlapatska LM; Sidorenko SP
Exp Oncol; 2012 Oct; 34(3):153-9. PubMed ID: 23069999
[TBL] [Abstract][Full Text] [Related]
38. Generation and Application of Bioluminescent CD95 Ligand Fusion Proteins.
Lang I; Kums J; Wajant H
Methods Mol Biol; 2017; 1557():63-77. PubMed ID: 28078583
[TBL] [Abstract][Full Text] [Related]
39. Early activation of CD95 is limited and localized to the cytotoxic synapse.
Sánchez MF; Murad F; Gülcüler Balta GS; Martin-Villalba A; García-Sáez AJ; Carrer DC
FEBS J; 2018 Aug; 285(15):2813-2827. PubMed ID: 29797791
[TBL] [Abstract][Full Text] [Related]
40. CD95 Stimulation with CD95L and DISC Analysis.
Le Gallo M; Legembre P
Methods Mol Biol; 2017; 1557():11-18. PubMed ID: 28078578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
